Insider Transactions in Q1 2024 at Ngm Biopharmaceuticals Inc (NGM)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 16
2024
|
David J Woodhouse Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,032
-9.0%
|
$13,032
$1.34 P/Share
|
|
Jan 16
2024
|
Valerie L Pierce |
SELL
Payment of exercise price or tax liability
|
Direct |
5,021
-8.31%
|
$5,021
$1.34 P/Share
|
|
Jan 16
2024
|
Irene Perlich Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,025
-10.25%
|
$1,025
$1.34 P/Share
|
|
Jan 16
2024
|
Hsiao D Lieu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,430
-9.1%
|
$5,430
$1.34 P/Share
|